These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Incidence of pelvic lymph node metastasis using modern FIGO staging and sentinel lymph node mapping with ultrastaging in surgically staged patients with endometrioid and serous endometrial carcinoma. Mueller JJ; Pedra Nobre S; Braxton K; Alektiar KM; Leitao MM; Aghajanian C; Ellenson LH; Abu-Rustum NR Gynecol Oncol; 2020 Jun; 157(3):619-623. PubMed ID: 32247604 [TBL] [Abstract][Full Text] [Related]
7. Ultrastaging of 'negative' pelvic lymph nodes in patients with low- and intermediate-risk endometrioid endometrial cancer who developed non-vaginal recurrences. Gill SE; Garzon S; Multinu F; Hokenstad AN; Casarin J; Cappuccio S; McGree ME; Weaver AL; Cliby WA; Keeney GL; Mariani A Int J Gynecol Cancer; 2021 Dec; 31(12):1541-1548. PubMed ID: 34706876 [TBL] [Abstract][Full Text] [Related]
8. Incidence of sentinel lymph node metastases in apparent early-stage endometrial cancer: a multicenter observational study. De Vitis LA; Fumagalli D; Schivardi G; Capasso I; Grcevich L; Multinu F; Cucinella G; Occhiali T; Betella I; Guillot BE; Pappalettera G; Shahi M; Fought AJ; McGree M; Reynolds E; Colombo N; Zanagnolo V; Aletti G; Langstraat C; Mariani A; Glaser G Int J Gynecol Cancer; 2024 May; 34(5):689-696. PubMed ID: 38514100 [TBL] [Abstract][Full Text] [Related]
9. Absence of prognostic value of lymphovascular space invasion in patients with endometrial cancer and negative sentinel lymph nodes. Matanes E; Eisenberg N; Lau S; Salvador S; Ferenczy A; Pelmus M; Gotlieb WH; Kogan L Gynecol Oncol; 2021 Aug; 162(2):256-261. PubMed ID: 34119364 [TBL] [Abstract][Full Text] [Related]
10. Endometrial cancer with positive sentinel lymph nodes: pathologic characteristics of metastases as predictors of extent of lymphatic dissemination and prognosis. Dinoi G; Ghoniem K; Huang Y; Zanfagnin V; Cucinella G; Langstraat C; Glaser G; Kumar A; Weaver A; McGree M; Fanfani F; Scambia G; Mariani A Int J Gynecol Cancer; 2024 Aug; 34(8):1172-1182. PubMed ID: 38658020 [TBL] [Abstract][Full Text] [Related]
11. Associations between lymphovascular space invasion, nodal recurrence, and survival in patients with surgical stage I endometrioid endometrial adenocarcinoma. Veade AE; Foote J; Ehrisman J; Broadwater G; Davidson BA; Lee PS; Secord AA; Berchuck A; Havrilesky LJ World J Surg Oncol; 2019 May; 17(1):80. PubMed ID: 31077193 [TBL] [Abstract][Full Text] [Related]
12. Comparison of a sentinel lymph node and a selective lymphadenectomy algorithm in patients with endometrioid endometrial carcinoma and limited myometrial invasion. Zahl Eriksson AG; Ducie J; Ali N; McGree ME; Weaver AL; Bogani G; Cliby WA; Dowdy SC; Bakkum-Gamez JN; Abu-Rustum NR; Mariani A; Leitao MM Gynecol Oncol; 2016 Mar; 140(3):394-9. PubMed ID: 26747778 [TBL] [Abstract][Full Text] [Related]
13. Low-Volume Lymph Node Metastasis Discovered During Sentinel Lymph Node Mapping for Endometrial Carcinoma. St Clair CM; Eriksson AG; Ducie JA; Jewell EL; Alektiar KM; Hensley ML; Soslow RA; Abu-Rustum NR; Leitao MM Ann Surg Oncol; 2016 May; 23(5):1653-9. PubMed ID: 26714954 [TBL] [Abstract][Full Text] [Related]
14. Isolated tumor cells and micrometastases in regional lymph nodes in stage I to II endometrial cancer. Todo Y; Kato H; Okamoto K; Minobe S; Yamashiro K; Sakuragi N J Gynecol Oncol; 2016 Jan; 27(1):e1. PubMed ID: 25925293 [TBL] [Abstract][Full Text] [Related]
15. Size of Sentinel Node Metastasis Predicts Non-sentinel Node Involvement in Endometrial Cancer. Baiocchi G; Mantoan H; Gonçalves BT; Faloppa CC; Kumagai LY; Badiglian-Filho L; da Costa AABA; De Brot L Ann Surg Oncol; 2020 May; 27(5):1589-1594. PubMed ID: 31686340 [TBL] [Abstract][Full Text] [Related]
16. Multicenter study comparing oncologic outcomes between two nodal assessment methods in patients with deeply invasive endometrioid endometrial carcinoma: A sentinel lymph node algorithm versus a comprehensive pelvic and paraaortic lymphadenectomy. Schlappe BA; Weaver AL; Ducie JA; Eriksson AGZ; Dowdy SC; Cliby WA; Glaser GE; Soslow RA; Alektiar KM; Makker V; Abu-Rustum NR; Mariani A; Leitao MM Gynecol Oncol; 2018 Nov; 151(2):235-242. PubMed ID: 30177461 [TBL] [Abstract][Full Text] [Related]
17. 2009 International Federation of Gynecology and Obstetrics (FIGO) stage IIIA endometrial cancer: oncologic outcomes based on involvement of adnexa, serosa, or both. Rios-Doria E; Abu-Rustum NR; Glaser G; McGree M; Eriksson AG; Pham M; Soliman P; Ataseven B; Alektiar K; Zamarin D; Leitao ML; Mueller J Int J Gynecol Cancer; 2024 Oct; 34(10):1580-1587. PubMed ID: 39074930 [TBL] [Abstract][Full Text] [Related]
18. Recurrence patterns and prognostic factors in lymphovascular space invasion-positive endometrioid endometrial cancer surgically confined to the uterus. Sahin H; Meydanli MM; Sari ME; Kocaman E; Cuylan ZF; Yalcin I; Coban G; Özen Ö; Sirvan L; Güngör T; Ayhan A Taiwan J Obstet Gynecol; 2019 Jan; 58(1):82-89. PubMed ID: 30638487 [TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of lymphovascular space invasion in early-stage low-grade endometrioid endometrial cancer: a fifteen-year retrospective Chinese cohort study. Sun B; Zhang X; Dong Y; Li X; Yang X; Zhao L; Wang J; Cheng Y World J Surg Oncol; 2024 Jul; 22(1):203. PubMed ID: 39080611 [TBL] [Abstract][Full Text] [Related]
20. The prognostic impact of substantial lymphovascular space invasion in women with node negative FIGO stage I uterine carcinoma. Bhatnagar AR; Ghanem AI; Alkamachi B; Allo G; Lin CH; Hijaz M; Elshaikh MA Gynecol Oncol; 2024 Sep; 188():44-51. PubMed ID: 38936280 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]